BioCentury
ARTICLE | Management Tracks

New board chairman at Dynavax

Plus: Arcturus, BioDelivery, Landmark Bio, Vitrolife, Novome and more

October 22, 2021 12:24 AM UTC

Vaccine company Dynavax Technologies Corp. (NASDAQ:DVAX) appointed Scott Myers chairman, replacing Andrew Hack, who has served as interim chairman since May 2020. Myers joins from AMAG Pharmaceuticals Inc., where he was CEO and a director. 

mRNA medicines company Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) hired Nirdosh Jagota as chief regulatory officer and Dushyant Varshney as CTO. Jagota was SVP in global regulatory affairs and clinical safety at Merck & Co. Inc. (NYSE:MRK) and Varshney was global head of manufacturing, science and technology at Kite Pharma...